Mylan NV (MYL)

MYL (NASDAQ:Drugs) EQUITY
$50.39
neg -0.06
-0.12%
Today's Range: 49.14 - 50.93 | MYL Avg Daily Volume: 6,753,800
Last Update: 02/09/16 - 1:01 PM EST
Volume: 2,789,709
YTD Performance: -6.73%
Open: $49.72
Previous Close: $50.45
52 Week Range: $37.59 - $76.69
Oustanding Shares: 491,747,016
Market Cap: 25,270,879,152
6-Month Chart
TheStreet Ratings Grade for MYL
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 5 5 5 4
Moderate Buy 0 0 0 0
Hold 5 5 5 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.00 2.00 2.00 2.00
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 23.47
Price Earnings Comparisons:
MYL Sector Avg. S&P 500
23.47 29.30 28.38
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
12.17% -6.38% 74.74%
GROWTH 12 Mo 3 Yr CAGR
Revenue 11.70 0.26 0.08
Net Income 48.90 0.73 0.20
EPS 47.70 0.99 0.26
Earnings for MYL:
EBITDA 1.89B
Revenue 7.72B
Average Earnings Estimates
Qtr (12/15) Qtr (03/16) FY (12/15) FY (12/16)
Average Estimate $1.25 $1.03 $4.35 $4.97
Number of Analysts 6 2 8 8
High Estimate $1.33 $1.03 $4.50 $5.14
Low Estimate $1.21 $1.03 $4.25 $4.82
Prior Year $1.05 $0.70 $3.56 $4.35
Growth Rate (Year over Year) 19.37% 47.14% 22.09% 14.38%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
The year has not started the way most pundits and prognosticators had envisioned.
Mylan and Endo International look like bargains at current prices.
Don't catch falling knives, and don't ignore dividends.
History indicates pharmaceutical companies with low multiples offer payoffs down the road.
Look for 2015's record run of mergers and acquisitions to continue.
These two will continue to churn out earnings growth.
CAT not going down on bearish news gets us closer to a bottom and buy recommendation.
Stocks are trading in a relatively narrow range, but are slightly down after Federal Reserve chair Janet Yellen hinted at a possible December rate hike.
There's very little movement on Wall Street right now as the European bourses close.

Thank God It's Friday! Real Money Pro($)

Good morning! Bret Jensen here.

Columnist Conversations

we'll take some exposure off the table. SOLD UPS APR 97.5 CALL AT 3.65 (in at 2.55) SOLD DOW MAR 47 CALL AT 1....
Straight to the point! http://realmoneypro.thestreet.com/articles/02/09/2016/heres-more-evidenc...
I just posted an intraday column on sentiment I think you will be interested in.
IWM
I have been adding on a scale. My cost basis is about $95.80

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.